home / stock / silo / silo quote
Last: | $0.17 |
---|---|
Change Percent: | -1.43% |
Open: | $0.1775 |
Close: | $0.17 |
High: | $0.18 |
Low: | $0.17 |
Volume: | 87,553 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.17 | $0.1775 | $0.17 | $0.18 | $0.17 | 87,553 | 09-14-2022 |
$0.175 | $0.1972 | $0.175 | $0.1972 | $0.1705 | 17,655 | 09-13-2022 |
$0.185 | $0.1984 | $0.185 | $0.1984 | $0.157 | 39,335 | 09-12-2022 |
$0.1986 | $0.18495 | $0.1986 | $0.1986 | $0.17 | 16,634 | 09-09-2022 |
$0.1894 | $0.21 | $0.1894 | $0.21 | $0.16 | 92,422 | 09-08-2022 |
$0.2 | $0.225 | $0.2 | $0.225 | $0.1559 | 64,703 | 09-07-2022 |
$0.1818 | $0.2 | $0.1818 | $0.22 | $0.1559 | 168,006 | 09-06-2022 |
$0.1807 | $0.1489 | $0.1807 | $0.2445 | $0.1489 | 992,419 | 09-02-2022 |
$0.142 | $0.133 | $0.142 | $0.142 | $0.1282 | 415,794 | 09-01-2022 |
$0.1305 | $0.1344 | $0.1305 | $0.135 | $0.1287 | 42,117 | 08-31-2022 |
$0.13 | $0.132 | $0.13 | $0.132 | $0.1285 | 66,664 | 08-30-2022 |
$0.1351 | $0.129 | $0.1351 | $0.1379 | $0.129 | 140,656 | 08-29-2022 |
$0.1379 | $0.13 | $0.1379 | $0.1379 | $0.1283 | 3,355 | 08-26-2022 |
$0.1281 | $0.1379 | $0.1281 | $0.1389 | $0.1281 | 153,078 | 08-25-2022 |
$0.135 | $0.1343 | $0.135 | $0.1396 | $0.1275 | 141,500 | 08-24-2022 |
$0.1304 | $0.1399 | $0.1304 | $0.14 | $0.1304 | 43,600 | 08-23-2022 |
$0.1387 | $0.13795 | $0.1387 | $0.1387 | $0.136 | 30,800 | 08-22-2022 |
$0.13505 | $0.1291 | $0.13505 | $0.1399 | $0.1291 | 158,300 | 08-19-2022 |
$0.1291 | $0.1301 | $0.1291 | $0.1329 | $0.1291 | 120,500 | 08-18-2022 |
$0.133 | $0.1305 | $0.133 | $0.133 | $0.1305 | 9,289 | 08-17-2022 |
News, Short Squeeze, Breakout and More Instantly...
SILO Pharma Inc Company Name:
SILO Stock Symbol:
OTCMKTS Market:
Silo Pharma (NASDAQ: SILO) is a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments. The company today announced positive data in the final validation report from the recent pharm...
Intranasal Delivery of SPC-15 shows rapid and effective drug exposure for PTSD Therapy SARASOTA, FL, April 23, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing...
SPC-14 shows cognitive and stress reduction benefits in preclinical models SARASOTA, FL, April 10, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing n...